Glycopeptide resistance in gram-positive cocci: a review

S Sujatha1, Ira Praharaj

  • 1Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry 605006, India.

Insights

Vancomycin resistance in bacteria like Enterococci (VRE) and Staphylococcus aureus is a growing global threat, limiting treatment options. This review explores the genetic basis, detection, and emerging therapies for these resistant gram-positive pathogens.

Area of Science:

  • Clinical microbiology and infectious diseases
  • Molecular biology of antimicrobial resistance
  • Bacterial genetics and evolution

Background:

  • Vancomycin-resistant enterococci (VRE) and vancomycin-nonsusceptible Staphylococcus aureus are significant nosocomial pathogens.
  • The rise of these resistant strains severely restricts therapeutic choices for treating serious infections.
  • Increasing vancomycin resistance is also observed in coagulase-negative staphylococci.

Purpose of the Study:

  • To elucidate the genetic underpinnings of vancomycin resistance in Enterococcus species and Staphylococcus aureus.
  • To discuss critical aspects of detecting vancomycin resistance in these gram-positive bacteria.
  • To review glycopeptide resistance in coagulase-negative staphylococci and vancomycin tolerance in Streptococcus pneumoniae.

Main Methods:

  • Review of existing literature on the genetic basis of vancomycin resistance.
  • Analysis of diagnostic considerations for identifying vancomycin-resistant gram-positive bacteria.
  • Synthesis of information on therapeutic strategies against emerging resistant pathogens.

Main Results:

  • Detailed exploration of the genetic mechanisms conferring vancomycin resistance in key pathogens.
  • Emphasis on the challenges and importance of accurate detection methods for resistance.
  • Overview of current and developing treatment options for infections caused by these multidrug-resistant organisms.

Conclusions:

  • Understanding the genetic basis of vancomycin resistance is crucial for combating its spread.
  • Effective detection strategies are vital for appropriate patient management and infection control.
  • Continued research into novel therapeutic agents is necessary to address the limited treatment landscape.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gram-negative Bacterial Protein Secretion Systems01:17

Gram-negative Bacterial Protein Secretion Systems

Gram-negative bacteria utilize sophisticated protein secretion systems to transport proteins across their double-membrane envelope into the extracellular environment or host cells. Based on their mechanism of action, these systems are classified into one-step and two-step pathways.One-Step Secretion Systems (Types I, III, IV, and VI)One-step secretion systems bypass the periplasm entirely, forming a continuous channel that spans both the inner and outer membranes:Type I Secretion System (T1SS):...